Represented several European pharmaceutical companies in matters involving the unauthorised sale of medicinal products not intended for the Uzbekistan market. The engagement included the development of a legal position at the intersection of customs, pharmaceutical, and intellectual property law, as well as engagement with regulators to stop the unlawful circulation of goods.